Access Resources
5081 - 5090 of 7540 Results
Title
Year
- Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins2018RESTRICTEDTitle: Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteinsJournal Name: EMBO reportsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.15252/embr.201745680Best OA location URL: https://doi.org/10.15252/embr.201745680Citation Count: 42
-
RESTRICTEDTitle: Increased substantia nigra echogenicity in LRRK2 family members without mutationsJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 9Start Page: 1504End Page: 1505Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27443Best OA location URL: https://europepmc.org/articles/pmc6346431?pdf=renderCitation Count: 1
-
RESTRICTEDTitle: Validation of the MDS clinical diagnostic criteria for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1601End Page: 1608Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27362Citation Count: 173
- Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt–Jakob Disease and Synucleinopathy2018RESTRICTEDTitle: Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt–Jakob Disease and SynucleinopathyJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 56Issue #: 5Start Page: 3476End Page: 3483Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-018-1313-4Citation Count: 22
- Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy2018RESTRICTEDTitle: Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsyJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 136Issue #: 5Start Page: 709End Page: 727Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-018-1900-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-018-1900-5.pdfCitation Count: 47
- Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model2018RESTRICTEDTitle: Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease modelJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-018-0062-4Best OA location URL: https://www.nature.com/articles/s41531-018-0062-4.pdfCitation Count: 59
-
RESTRICTEDTitle: Cognition among individuals along a spectrum of increased risk for Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 13Issue #: 8Start Page: e0201964End Page: e0201964Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0201964Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0201964&type=printableCitation Count: 31
-
RESTRICTEDTitle: The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease targetJournal Name: BrainPublisher: Oxford University Press (OUP)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awy215Best OA location URL: https://academic.oup.com/brain/article-pdf/141/9/2721/25590456/awy215.pdfCitation Count: 32
- Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators2018RESTRICTEDTitle: Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulatorsJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 25Issue #: 11Start Page: 2786End Page: 2799Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41380-018-0206-2Best OA location URL: https://www.nature.com/articles/s41380-018-0206-2.pdfCitation Count: 26
-